Burisch, J, Vardi, H, Schwartz, D, Friger, M, Kiudelis, G, Kupčinskas, J, Fumery, M, Gower-rousseau, C, Lakatos, L, Lakatos, PL, D'incà, R, Sartini, A, Valpiani, D, Giannotta, M, Arebi, N, Duricova, D, Bortlik, M, Chetcuti Zammit, S, Ellul, P, Pedersen, N, Kjeldsen, J, Midjord, JMM, Nielsen, KR, Winther Andersen, K, Andersen, V, Katsanos, KH, Christodoulou, DK, Domislovic, V, Krznaric, Z, Sebastian, S, Oksanen, P, Collin, P, Barros, L, Magro, F, Salupere, R, Kievit, HAL, Goldis, A, Kaimakliotis, IP, Dahlerup, JF, Eriksson, C, Halfvarson, J, Fernandez, A, Hernandez, V, Turcan, S, Belousova, E
, Langholz, E, Munkholm, P, Odes, S, Turk, N
, Vind, I & Epi-IBD group 2020, '
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study',
The Lancet Gastroenterology and Hepatology, bind 5, nr. 5, s. 454-464.
https://doi.org/10.1016/S2468-1253(20)30012-1